Transmission potential of two chimeric chikungunya vaccine candidates in the urban mosquito vectors, Aedes aegypti and Ae. albopictus

Keyphrases

• Vaccine Candidate 100%
• Mosquito Vectors 100%
• Aedes Aegypti 100%
• Urban Mosquitoes 100%
• Chikungunya Virus (CHIKV) 100%
• Aedes Albopictus 100%
• Transmission Potential 100%
• Chikungunya Vaccine 100%
• Alphavirus 66%
• Virus 33%
• Vaccine Strain 33%
• Non-structural Protein 33%
• Structural Genes 33%
• Attenuated Vaccine Strains 33%
• Infectivity 33%
• Mosquito-borne 33%
• Structural Protein Genes 33%
• Venezuelan Equine Encephalitis Virus 33%
• Major Outbreak 33%
• Asia 33%
• Africa 33%
• Vaccinees 33%
• Viremic 33%
• Genetic Modification 33%
• Chimeric Vaccine 33%
• Infection Rate 33%
• Virus Vector 33%
• Eastern Equine Encephalitis Virus 33%
• TC83 33%
• Intrathoracic Inoculation 33%
• Live Vaccine Strain 33%
• Attenuated Strain 33%
• Dissemination Rate 33%
• Midgut Barrier 33%
• Modified Live Vaccine 33%
• Low Potential 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Infection 100%
• Vaccine Strain 100%
• Mosquito Vector 100%
• Aedes aegypti 100%
• Chikungunya 100%
• Chikungunya Virus 100%
• Live Vaccine 66%
• Alphavirus 66%
• Structural Protein 33%
• Venezuelan Equine Encephalitis Virus 33%
• Viral Vector 33%
• Chimeric Vaccine 33%
• Eastern Equine Encephalitis Virus 33%

Immunology and Microbiology

• Aedes aegypti 100%
• Chikungunya Virus 100%
• Alphavirus 66%
• Attenuated Vaccine 66%
• Live Vaccine 66%
• Structural Gene 33%
• Revertant 33%
• Midgut 33%
• Venezuelan Equine Encephalitis Virus 33%
• Viral Vector 33%
• Eastern Equine Encephalitis Virus 33%